IP Library Granted Patent US 7,462,487
Granted Patent B2
US 7,462,487 · App. 10/944,083 · Granted Dec 9, 2008

Cell culture media

Assignee: Raven biotechnologies, inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,462,487
App. No.
10/944,083
Granted
Dec 9, 2008
Kind
B2
Abstract

Methods are taught for culturing mammalian cells, preferably human cells, to improve production of proteins, recombinant or endogenous. Methods are also provided for the growth and long-term survival of cell lines, particularly cell lines established from primary culture. Cell culture media are also provided, contained varying levels of selected amino acids, supplemented with various growth factors and trace elements. In additionally, the media are optionally serum-free, and preferably use an energy source other than glucose. The media are particularly suitable for the primary culture and long-term culture of human fetal cells.

Claims (1)

1. A composition of serum-free cell culture medium having the following components present at the indicated final concentrations: calcium chloride at 180 mg/L, potassium chloride at 298 mg/L, potassium nitrate at 0.0126 mg/L, magnesium sulfate at 68 mg/L, magnesium chloride at 37 mg/L, sodium chloride at 6200 mg/L, sodium bicarbonate at 1200 mg/L, sodium phosphate at 43 mg/L, sodium phosphate (dibasic) at 88 mg/L, sodium selenite at 0.0126 mg/L, ammonium metavanadate 3.51×10 −4 mg/L, molybdic acid at 3.72×10 −3 mg/L, cupric sulfate at 7.5×10 4 mg/L, ferrous sulfate at 0.25 mg/L, manganese sulfate at 4.53×10 −5 mg/L, zinc sulfate at 0.259 mg/L, fructose at 2000 mg/L, HEPES at 15 mM, putrescine at 0.048 mg/L, thioctic acid at 0.0618 mg/L, sodium pyruvate at 110.03 mg/L, linoleic acid at 0.025 mg/L, 1-alanine at 20.173 mg/L, 1-asparagine (freebase) at 17.5 mg/L, 1-asparagine at 122.01 mg/L, 1-aspartic acid at 24.99 mg/L, 1-cystine at 63.98 mg/L, 1-cysteine at 5.268 mg/L, glutamic acid at 56.9 mg/L, 1-glutamine at 600 mg/L, glycine at 23.25 mg/L, 1-histidine at 35.69 mg/L, 1-isoleucine at 74.68 mg/L, leucine at 77.43 mg/L, 1-lysine at 113.16 mg/L, 1-methionine at 22.34 mg/L, 1-phenylalanine at 47.69 mg/L, 1-proline at 38.36 mg/L, 1-seine at 32.55 mg/L, 1-threonine at 70.07 mg/L, 1-tryptophan at 11.81 mg/L, 1-tyrosine at 75.17 mg/L, 1-valine at 69.31 mg/L, biotin at 1.13 ×102 mg/L, D-Ca-pantothenate at 2.87 mg/L, choline chloride at 6.99 mg/L, folic acid at 3.2 mg/L, 1-inositol at 10.45 mg/L, niacinamide at 2.81 mg/L, pyriodxal at 2.8 mg/L, pyridoxine at 1.85×10 −2 mg/L, riboflavin at 0.291 mg/L, thiamine at 2.9 mg/L, vitamin B 12 at 4.99×10 −2 mg/L.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2014
From: MACROGENICS WEST, INC.
To: MACROGENICS, INC.
Reel/Frame 034630/0402 →
SECURITY AGREEMENT Recorded Jan 12, 2011
From: DIADEXUS, INC. (FORMERLY VAXGEN, INC.)
To: RAVEN BIOTECHNOLOGIES, INC.
Reel/Frame 025622/0237 →
SECURITY AGREEMENT Recorded Jun 13, 2008
From: RAVEN BIOTECHNOLOGIES, INC.
To: VAXGEN, INC.
Reel/Frame 021096/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2005
From: TSAO, MARY C.
To: RAVEN BIOTECHNOLOGIES, INC.
Reel/Frame 015576/0961 →
Continuity (2)
Provisional Application 6050467400 · Sep 18, 2003
Related Publication 20050101011A1 · May 12, 2005